Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 40c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $84.91 -4.15%
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($1.26), $0.40 worse than the analyst estimate of ($0.86). Revenue for the quarter came in at $27.77 million versus the consensus estimate of $53.9 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird Upgrades Titan Machinery (TITN) to Outperform
- Jefferies Starts Braveheart Bio (BRVE) at Buy
- Blue Owl leads $2.4 billion debt deal for Iren data center
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
